My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.

    Bodmer M, Meier C, Krähenbühl S, Jick SS, Meier CR.

    Diabetes Care. 2008 Nov;31(11):2086-91. Epub 2008 Sep 9.PMID: 18782901 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Balancing risk and benefit with oral hypoglycemic drugs.

    Hamnvik OP, McMahon GT.

    Mt Sinai J Med. 2009 Jun;76(3):234-43.PMID: 19421967 [PubMed - indexed for MEDLINE]Related articles

    3.

    Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    Salpeter S, Greyber E, Pasternak G, Salpeter E.

    Cochrane Database Syst Rev. 2003;(2):CD002967. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD002967. PMID: 12804446 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    Salpeter S, Greyber E, Pasternak G, Salpeter E.

    Cochrane Database Syst Rev. 2002;(2):CD002967. Review. Update in: Cochrane Database Syst Rev. 2003;(2):CD002967. PMID: 12076461 [PubMed - indexed for MEDLINE]Related articles

    5.

    Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

    Salpeter S, Greyber E, Pasternak G, Salpeter E.

    Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002967. Review.PMID: 16437448 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.

    Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CA.

    Drugs Aging. 2008;25(7):611-22.PMID: 18582148 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lactic acidosis rates in type 2 diabetes.

    Brown JB, Pedula K, Barzilay J, Herson MK, Latare P.

    Diabetes Care. 1998 Oct;21(10):1659-63. Erratum in: Diabetes Care 1998 Dec;21(12):2203. PMID: 9773726 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

    Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

    Diabetes Care. 2006 Feb;29(2):254-8.PMID: 16443869 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study.

    Kamber N, Davis WA, Bruce DG, Davis TM.

    Med J Aust. 2008 Apr 21;188(8):446-9.PMID: 18429709 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Biguanide related lactic acidosis: incidence and risk factors.

    Aguilar C, Reza A, García JE, Rull JA.

    Arch Med Res. 1992 Spring;23(1):19-24.PMID: 1308787 [PubMed - indexed for MEDLINE]Related articles

    11.

    The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.

    McAlister FA, Eurich DT, Majumdar SR, Johnson JA.

    Eur J Heart Fail. 2008 Jul;10(7):703-8. Epub 2008 Jun 19.PMID: 18571471 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rosiglitazone and myocardial infarction in patients previously prescribed metformin.

    Dormuth CR, Maclure M, Carney G, Schneeweiss S, Bassett K, Wright JM.

    PLoS One. 2009 Jun 27;4(6):e6080.PMID: 19562036 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Incidence of lactic acidosis in metformin users.

    Stang M, Wysowski DK, Butler-Jones D.

    Diabetes Care. 1999 Jun;22(6):925-7.PMID: 10372243 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Rates of hypoglycemia in users of sulfonylureas.

    van Staa T, Abenhaim L, Monette J.

    J Clin Epidemiol. 1997 Jun;50(6):735-41.PMID: 9250272 [PubMed - indexed for MEDLINE]Related articles

    15.

    Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.

    Koro CE, Bowlin SJ, Weiss SR.

    Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):697-703.PMID: 15654719 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs]

    Scheen AJ.

    Rev Med Liege. 2002 May;57(5):352-6. French. PMID: 12143186 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.

    Brauchli YB, Jick SS, Curtin F, Meier CR.

    J Am Acad Dermatol. 2008 Mar;58(3):421-9. Epub 2008 Jan 14.PMID: 18194825 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metformin-associated lactic acidosis: a rare or very rare clinical entity?

    Chan NN, Brain HP, Feher MD.

    Diabet Med. 1999 Apr;16(4):273-81. Review.PMID: 10220200 [PubMed - indexed for MEDLINE]Related articles

    19.

    Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.

    Shorr RI, Ray WA, Daugherty JR, Griffin MR.

    Arch Intern Med. 1997 Aug 11-25;157(15):1681-6.PMID: 9250229 [PubMed - indexed for MEDLINE]Related articles

    20.

    Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

    Johnson JA, Majumdar SR, Simpson SH, Toth EL.

    Diabetes Care. 2002 Dec;25(12):2244-8.PMID: 12453968 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity